NBIX
NASDAQStockNeurocrine Biosciences, Inc.
$128.03-1.51 (-1.17%)
52-Week Range
$87.54
$155.63
Key Stats
Market Cap
12.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.36
Volume
457.7K
Avg Volume
1.0M
Performance
1M
-7.03%
3M
-17.06%
6M
-9.01%
YTD
-9.12%
1Y
+17.24%
3Y
+33.83%
5Y
+31.64%
Price Chart
ETF Exposure
NBIX is held by 216 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | 0.39% |
| PTMC | Pacer Trendpilot US Mid Cap ETF | 0.39% |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | 0.39% |
| JGRO | JPMorgan Active Growth ETF | 0.38% |
| IWP | iShares Russell Mid-Cap Growth ETF | 0.37% |
| FLDZ | RiverNorth Patriot ETF | 0.37% |
| DMRM | DeltaShares S&P 400 Managed Risk ETF | 0.36% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.35% |
| STXM | Strive Mid-Cap ETF | 0.34% |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 0.31% |
| MVV | ProShares - Ultra MidCap400 | 0.31% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.31% |
| SFYX | SoFi Next 500 ETF | 0.30% |
| USMV | iShares MSCI USA Min Vol Factor ETF | 0.30% |
| FSMD | FIDELITY SMALL-MID MULTIFACTOR ETF | 0.29% |
| BALQ | iShares Nasdaq Premium Income Active ETF | 0.28% |
| SAGP | Strategas Global Policy Opportunities ETF | 0.28% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.28% |
| UMDD | ProShares - UltraPro MidCap 400 | 0.27% |
| SCHM | Schwab U.S. Mid-Cap ETF | 0.27% |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.26% |
| JPME | JPMorgan Diversified Return U.S. Mid Cap Equity ETF | 0.24% |
| STMB | iShares Trust - iShares Factors US Mid Blend Style ETF | 0.23% |
| MXDU | Nationwide Maximum Diversification U.S. Core Equity ETF | 0.23% |
| USMF | WisdomTree U.S. Multifactor Fund | 0.23% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.22% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.22% |
| BLES | Inspire Global Hope ETF | 0.22% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.22% |
| IYH | iShares U.S. Healthcare ETF | 0.22% |
| BFOR | Barron's 400SM ETF | 0.21% |
| PWS | Pacer WealthShield ETF | 0.21% |
| VHT | Vanguard Health Care ETF | 0.21% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.20% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.20% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.20% |
| EUSA | iShares MSCI USA Equal Weighted ETF | 0.19% |
| JHMM | John Hancock Investments - Multifactor Mid Cap ETF | 0.19% |
| OPTZ | Optimize Strategy Index ETF | 0.19% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.18% |
| VB | Vanguard Small-Cap ETF | 0.18% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.17% |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 0.17% |
| SIZE | iShares MSCI USA Size Factor ETF | 0.17% |
| VXF | Vanguard Extended Market ETF | 0.17% |
| SMMD | iShares Russell 2500 ETF | 0.17% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.16% |
| ONEV | State Street SPDR Russell 1000 Low Volatility Focus ETF | 0.16% |
| ACWV | iShares MSCI Global Min Vol Factor ETF | 0.15% |
| CFA | VictoryShares US 500 Volatility Wtd ETF | 0.15% |
About NBIX ETF Exposure
Neurocrine Biosciences, Inc. (NBIX) is held by 216 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.8B, NBIX is a widely held institutional stock. The stock currently trades at $128.03. Investors can gain exposure to NBIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NBIX, sorted by portfolio weight.